Venous Congestion, Endothelial and Neurohormonal Activation in Acute Decompensated Heart Failure: Cause or Effect?

被引:44
|
作者
Colombo P.C. [1 ]
Doran A.C. [1 ]
Onat D. [2 ]
Wong K.Y. [3 ]
Ahmad M. [3 ]
Sabbah H.N. [4 ]
Demmer R.T. [5 ]
机构
[1] Division of Cardiology, College of Physicians & Surgeons, Department of Medicine, Columbia University, 622 West 168th Street, PH 12-134, New York, 10032, NY
[2] Division of Cardiology, College of Physicians & Surgeons, Department of Medicine, Columbia University, 630 West 168th Street, P&S 17-401, New York, 10032, NY
[3] Division of Cardiology, College of Physicians & Surgeons, Department of Medicine, Columbia University, 630 West 168th Street, P&S 8-510, New York, 10032, NY
[4] Division of Cardiovascular Medicine, Department of Medicine, Henry Ford Heart and Vascular Institute, 2799 West Grand Boulevard, Detroit, 48202, MI
[5] Department of Epidemiology, Mailman School of Public Health, Columbia University, 722 West 168th Street, 7th floor, New York, 10032, NY
基金
美国国家卫生研究院;
关键词
Endothelial; Heart failure;
D O I
10.1007/s11897-015-0254-8
中图分类号
学科分类号
摘要
Venous congestion and endothelial and neurohormonal activation are known to occur in acute decompensated heart failure (ADHF), yet the temporal role of these processes in the pathophysiology of decompensation is not fully understood. Conventional wisdom presumes congestion to be a consequence of worsening cardiovascular function; however, the biomechanically driven effects of venous congestion are biologically plausible contributors to ADHF that remain largely unexplored in vivo. Recent experimental evidence from human models suggests that fluid accumulation and venous congestion are not simply consequences of poor cardiovascular function, but rather are fundamental pro-oxidant, pro-inflammatory, and hemodynamic stimuli that contribute to acute decompensation. The latest advances in the monitoring of volume status using implantable devices allow for the detection of venous congestion before symptoms arise. This may ultimately lead to improved treatment strategies including not only diuretics, but also specific, adjuvant interventions to counteract endothelial and neurohormonal activation during early preclinical decompensation. © 2015, Springer Science+Business Media New York.
引用
收藏
页码:215 / 222
页数:7
相关论文
共 50 条
  • [31] Neurohormonal prediction of mortality following admission for decompensated heart failure
    Aronson, D
    Burger, AJ
    AMERICAN JOURNAL OF CARDIOLOGY, 2003, 91 (02): : 245 - +
  • [32] Lack of correlation between different congestion markers in acute decompensated heart failure
    Haag, Svenja
    Jobs, Alexander
    Stiermaier, Thomas
    Fichera, Carlo-Federico
    Paitazoglou, Christina
    Eitel, Ingo
    Desch, Steffen
    Thiele, Holger
    CLINICAL RESEARCH IN CARDIOLOGY, 2023, 112 (01) : 75 - 86
  • [33] Relationship of Liver Stiffness With Congestion in Patients Presenting With Acute Decompensated Heart Failure
    Soloveva, Anzhela
    Kobalava, Zhanna
    Fudim, Marat
    Ambrosy, Andrew P.
    Villevalde, Svetlana
    Bayarsaikhan, Munkhtsetseg
    Garmash, Irina
    Naumenko, Maksim
    JOURNAL OF CARDIAC FAILURE, 2019, 25 (03) : 176 - 187
  • [34] The burden of congestion monitoring in acute decompensated heart failure: The need for multiparametric approach
    Scicchitano, Pietro
    Massari, Francesco
    IJC HEART & VASCULATURE, 2024, 54
  • [35] Lack of correlation between different congestion markers in acute decompensated heart failure
    Svenja Haag
    Alexander Jobs
    Thomas Stiermaier
    Carlo-Federico Fichera
    Christina Paitazoglou
    Ingo Eitel
    Steffen Desch
    Holger Thiele
    Clinical Research in Cardiology, 2023, 112 : 75 - 86
  • [36] Total bilirubin increase is associated with congestion and hypoperfusion in acute decompensated heart failure
    Soloveva, A. Anzhela
    Villevalde, S.
    Kobalava, Z.
    EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 : 362 - 362
  • [37] Prevalence, predictors and clinical outcome of residual congestion in acute decompensated heart failure
    Rubio-Gracia, Jorge
    Demissei, Biniyam G.
    ter Maaten, Jozine M.
    Cleland, John G.
    O'Connor, Christopher M.
    Metra, Marco
    Ponikowski, Piotr
    Teerlink, John R.
    Cotter, Gad
    Davison, Beth A.
    Givertz, Michael M.
    Bloomfield, Daniel M.
    Dittrich, Howard
    Damman, Kevin
    Perez-Calvo, Juan I.
    Voors, Adriaan A.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 258 : 185 - 191
  • [38] Effect of Beta-Blockade on autonomic modulation of heart rate and neurohormonal profile in decompensated heart failure
    Aronson, D
    Burger, AJ
    ANNALS OF NONINVASIVE ELECTROCARDIOLOGY, 2001, 6 (02) : 98 - 106
  • [39] Acute decompensated heart failure
    Neuenschwander, James F., II
    Baliga, Ragavendra R.
    CRITICAL CARE CLINICS, 2007, 23 (04) : 737 - +
  • [40] Effect of Nesiritide in Patients with Acute Decompensated Heart Failure
    O'Connor, C. M.
    Starling, R. C.
    Hernandez, A. F.
    Armstrong, P. W.
    Dickstein, K.
    Hasselblad, V.
    Heizer, G. M.
    Komajda, M.
    Massie, B. M.
    McMurray, J. J. V.
    Nieminen, M. S.
    Reist, C. J.
    Rouleau, J. L.
    Swedberg, K.
    Adams, K. F., Jr.
    Anker, S. D.
    Atar, D.
    Battler, A.
    Botero, R.
    Bohidar, N. R.
    Butler, J.
    Clausell, N.
    Corbalan, R.
    Costanzo, M. R.
    Dahlstrom, U.
    Deckelbaum, L. I.
    Diaz, R.
    Dunlap, M. E.
    Ezekowitz, J. A.
    Feldman, D.
    Felker, G. M.
    Fonarow, G. C.
    Gennevois, D.
    Gottlieb, S. S.
    Hill, J. A.
    Hollander, J. E.
    Howlett, J. G.
    Hudson, M. P.
    Kociol, R. D.
    Krum, H.
    Laucevicius, A.
    Levy, W. C.
    Mendez, G. F.
    Metra, M.
    Mittal, S.
    Oh, B. -H.
    Pereira, N. L.
    Ponikowski, P.
    Wilson, W. H.
    Tanomsup, S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (01): : 32 - 43